Journal: RSC Advances

Article Title: Preparation and characterization of novel PMMA bone cement containing 3,4-dichloro-5-hydroxyfuran-2(5 H )-one †

doi: 10.1039/d4ra06607c

Figure Lengend Snippet: Formulation of PMMA cement and various concentrations of DHF-MAA bone cement (percentage by mass of each component)

Article Snippet: PMMA bone cement (OSTEOPAL®V) and ALBC (PALACOS®R+G) were purchased from Heraeus Medical GmbH; DHF was purchased from Guangzhou Ronfan Technology Co., Ltd; MAA from Shanghai Macklin Biochemical Technology Co., Ltd; dichloromethane (DCM), 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDCI), and 4-dimethylaminopyridine (DMAP) were purchased from Shanghai Macklin Biochemical Co., Ltd; Staphylococcus aureus (ACTT 25923) was obtained from the Laboratory Department of The Second People's Hospital of Hefei.

Techniques: Formulation

Journal: RSC Advances

Article Title: Preparation and characterization of novel PMMA bone cement containing 3,4-dichloro-5-hydroxyfuran-2(5 H )-one †

doi: 10.1039/d4ra06607c

Figure Lengend Snippet: FT-IR spectra of the powder of PMMA cement and three DHF-MAA bone cement formulations.

Article Snippet: PMMA bone cement (OSTEOPAL®V) and ALBC (PALACOS®R+G) were purchased from Heraeus Medical GmbH; DHF was purchased from Guangzhou Ronfan Technology Co., Ltd; MAA from Shanghai Macklin Biochemical Technology Co., Ltd; dichloromethane (DCM), 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDCI), and 4-dimethylaminopyridine (DMAP) were purchased from Shanghai Macklin Biochemical Co., Ltd; Staphylococcus aureus (ACTT 25923) was obtained from the Laboratory Department of The Second People's Hospital of Hefei.

Techniques:

Journal: RSC Advances

Article Title: Preparation and characterization of novel PMMA bone cement containing 3,4-dichloro-5-hydroxyfuran-2(5 H )-one †

doi: 10.1039/d4ra06607c

Figure Lengend Snippet: (A) Petri dishes containing extracts from specimens of PMMA cement and four DHF-MAA bone cement formulations; (B) bar charts of the antibacterial indexes of DHF-MAA bone cement formulations. (* indicates p < 0.05 compared to the 10% DHF-MAA bone cement group, ** indicates p < 0.001 compared to the 10% DHF-MAA bone cement group).

Article Snippet: PMMA bone cement (OSTEOPAL®V) and ALBC (PALACOS®R+G) were purchased from Heraeus Medical GmbH; DHF was purchased from Guangzhou Ronfan Technology Co., Ltd; MAA from Shanghai Macklin Biochemical Technology Co., Ltd; dichloromethane (DCM), 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDCI), and 4-dimethylaminopyridine (DMAP) were purchased from Shanghai Macklin Biochemical Co., Ltd; Staphylococcus aureus (ACTT 25923) was obtained from the Laboratory Department of The Second People's Hospital of Hefei.

Techniques:

Journal: RSC Advances

Article Title: Preparation and characterization of novel PMMA bone cement containing 3,4-dichloro-5-hydroxyfuran-2(5 H )-one †

doi: 10.1039/d4ra06607c

Figure Lengend Snippet: (A) Visual inspection of hemolysis test results for the PMMA cement and four DHF-MAA bone cement formulations; negative control group (−); and positive control group (+); (B) bar chart of hemolysis indexes for the PMMA cement group and four DHF-MAA bone cement formulations.

Article Snippet: PMMA bone cement (OSTEOPAL®V) and ALBC (PALACOS®R+G) were purchased from Heraeus Medical GmbH; DHF was purchased from Guangzhou Ronfan Technology Co., Ltd; MAA from Shanghai Macklin Biochemical Technology Co., Ltd; dichloromethane (DCM), 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDCI), and 4-dimethylaminopyridine (DMAP) were purchased from Shanghai Macklin Biochemical Co., Ltd; Staphylococcus aureus (ACTT 25923) was obtained from the Laboratory Department of The Second People's Hospital of Hefei.

Techniques: Negative Control, Positive Control

Journal: RSC Advances

Article Title: Preparation and characterization of novel PMMA bone cement containing 3,4-dichloro-5-hydroxyfuran-2(5 H )-one †

doi: 10.1039/d4ra06607c

Figure Lengend Snippet: Bar charts of RGR for the control group (complete medium), PMMA cement group and four DHF-MAA bone cement formulations day 1, day 3, and day 5. (* indicates p < 0.05 compared to the control group, and ^ indicates p < 0.05 when compared to the same concentration on day 1).

Article Snippet: PMMA bone cement (OSTEOPAL®V) and ALBC (PALACOS®R+G) were purchased from Heraeus Medical GmbH; DHF was purchased from Guangzhou Ronfan Technology Co., Ltd; MAA from Shanghai Macklin Biochemical Technology Co., Ltd; dichloromethane (DCM), 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDCI), and 4-dimethylaminopyridine (DMAP) were purchased from Shanghai Macklin Biochemical Co., Ltd; Staphylococcus aureus (ACTT 25923) was obtained from the Laboratory Department of The Second People's Hospital of Hefei.

Techniques: Control, Concentration Assay

Journal: RSC Advances

Article Title: Preparation and characterization of novel PMMA bone cement containing 3,4-dichloro-5-hydroxyfuran-2(5 H )-one †

doi: 10.1039/d4ra06607c

Figure Lengend Snippet: Compressive strength (A) and compressive modulus (B) of PMMA cement and three four DHF-MAA bone cement formulations. (* indicates p < 0.05 compared to the PMMA group, ^ indicates p < 0.05 when compared to the same group before aging.)

Article Snippet: PMMA bone cement (OSTEOPAL®V) and ALBC (PALACOS®R+G) were purchased from Heraeus Medical GmbH; DHF was purchased from Guangzhou Ronfan Technology Co., Ltd; MAA from Shanghai Macklin Biochemical Technology Co., Ltd; dichloromethane (DCM), 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDCI), and 4-dimethylaminopyridine (DMAP) were purchased from Shanghai Macklin Biochemical Co., Ltd; Staphylococcus aureus (ACTT 25923) was obtained from the Laboratory Department of The Second People's Hospital of Hefei.

Techniques:

Journal: RSC Advances

Article Title: Preparation and characterization of novel PMMA bone cement containing 3,4-dichloro-5-hydroxyfuran-2(5 H )-one †

doi: 10.1039/d4ra06607c

Figure Lengend Snippet: Slices of liver (A) and kidney (B) of mice from the normal saline (NS) group, PMMA cement group, and the DHF-MAA bone cement groups.

Article Snippet: PMMA bone cement (OSTEOPAL®V) and ALBC (PALACOS®R+G) were purchased from Heraeus Medical GmbH; DHF was purchased from Guangzhou Ronfan Technology Co., Ltd; MAA from Shanghai Macklin Biochemical Technology Co., Ltd; dichloromethane (DCM), 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDCI), and 4-dimethylaminopyridine (DMAP) were purchased from Shanghai Macklin Biochemical Co., Ltd; Staphylococcus aureus (ACTT 25923) was obtained from the Laboratory Department of The Second People's Hospital of Hefei.

Techniques: Saline

Journal: Nanomaterials

Article Title: Aptamer Functionalized Lipid Multilayer Gratings for Label-Free Analyte Detection

doi: 10.3390/nano10122433

Figure Lengend Snippet: Detection of thrombin from optimized aptamer functionalized gratings. The lipid composition was DOPC:DOTAP 40:60, pixels with a maximum green/red ratio were chosen, and gratings were fabricated to have maximum heights as determined by the relative fluorescence intensity. ( A ) Sensorgram showing a change in diffraction from the aptamer functionalized gratings upon exposure to thrombin. ( B ) Initial diffraction intensity of lipid gratings printed onto PMMA. ( C ) Processed image after exposure to thrombin for 10 min. The green channel after exposure was divided by the green channel before exposure to show the change in diffraction intensity.

Article Snippet: Finally, the lipid gratings were printed onto a Polymethylmethacrylate (PMMA) slide (HESA ® Glas HT, Notz Plastics, Brugg, Switzerland).

Techniques: Fluorescence